Ann B. Zimrin

1.8k total citations
45 papers, 1.3k citations indexed

About

Ann B. Zimrin is a scholar working on Otorhinolaryngology, Surgery and Hematology. According to data from OpenAlex, Ann B. Zimrin has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 10 papers in Surgery and 9 papers in Hematology. Recurrent topics in Ann B. Zimrin's work include Head and Neck Cancer Studies (11 papers), Blood transfusion and management (6 papers) and Head and Neck Surgical Oncology (6 papers). Ann B. Zimrin is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Blood transfusion and management (6 papers) and Head and Neck Surgical Oncology (6 papers). Ann B. Zimrin collaborates with scholars based in United States, Canada and Sweden. Ann B. Zimrin's co-authors include John R. Hess, Mortimer Poncz, Joel Bennett, Elias Schwartz, John R. Hess, Kevin J. Cullen, R. Taylor, Scott E. Strome, Mohan Suntharalingam and Jeffrey S. Wolf and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Ann B. Zimrin

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann B. Zimrin United States 17 327 255 235 213 213 45 1.3k
MA Blajchman Canada 17 832 2.5× 171 0.7× 213 0.9× 5 0.0× 688 3.2× 38 1.6k
Maria M. Aleman United States 14 502 1.5× 332 1.3× 162 0.7× 4 0.0× 30 0.1× 29 1.4k
Cheng‐Hwai Tzeng Taiwan 24 284 0.9× 340 1.3× 153 0.7× 22 0.1× 27 0.1× 90 1.3k
Matthias Peiper Germany 28 66 0.2× 446 1.7× 707 3.0× 50 0.2× 11 0.1× 117 2.2k
EK Kruithof Switzerland 17 1.3k 4.1× 378 1.5× 244 1.0× 3 0.0× 79 0.4× 31 2.6k
Barry Woodhams United Kingdom 22 741 2.3× 237 0.9× 145 0.6× 3 0.0× 37 0.2× 71 1.4k
A. Heyll Germany 22 1.2k 3.7× 412 1.6× 81 0.3× 14 0.1× 45 0.2× 65 1.7k
Hye Sung Won South Korea 22 31 0.1× 376 1.5× 227 1.0× 54 0.3× 9 0.0× 88 1.3k
Chao‐Hung Ho Taiwan 19 305 0.9× 67 0.3× 125 0.5× 6 0.0× 45 0.2× 55 837
Roberto Castelli Italy 21 553 1.7× 219 0.9× 164 0.7× 3 0.0× 34 0.2× 86 1.6k

Countries citing papers authored by Ann B. Zimrin

Since Specialization
Citations

This map shows the geographic impact of Ann B. Zimrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann B. Zimrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann B. Zimrin more than expected).

Fields of papers citing papers by Ann B. Zimrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann B. Zimrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann B. Zimrin. The network helps show where Ann B. Zimrin may publish in the future.

Co-authorship network of co-authors of Ann B. Zimrin

This figure shows the co-authorship network connecting the top 25 collaborators of Ann B. Zimrin. A scholar is included among the top collaborators of Ann B. Zimrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann B. Zimrin. Ann B. Zimrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Xin, et al.. (2024). Recurrent Stent Thrombosis Following Myocardial Infarction Associated With VITT-Like Antibodies. JACC Case Reports. 29(5). 102234–102234. 1 indexed citations
2.
Bialkowski, Walter, Sylvia Tan, Alan E. Mast, et al.. (2019). Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage. Thrombosis Research. 185. 109–118. 3 indexed citations
4.
Kreuziger, Lisa Baumann, Gustaf Edgren, Ronald G. Hauser, et al.. (2018). Red Blood Transfusion Does Not Increase Risk for Venous or Arterial Thrombosis. Blood. 132. 415–415. 2 indexed citations
5.
Baer, Maria R., et al.. (2018). Thrombotic microangiopathy in the setting of human immunodeficiency virus infection: High incidence of severe thrombocytopenia. Journal of Clinical Apheresis. 33(3). 342–348. 8 indexed citations
6.
Gottschall, Jerry, Yanyun Wu, Darrell J. Triulzi, et al.. (2017). The Epidemiology of Platelet Transfusions: An Analysis of Platelet Use at 12 U.S. Hospitals. Blood. 130. 2405–2405. 16 indexed citations
7.
Zimrin, Ann B., et al.. (2016). Use of the APACHE II score to assess impact of therapeutic plasma exchange for critically ill patients with hypertriglyceride-induced pancreatitis. Transfusion and Apheresis Science. 56(2). 123–126. 20 indexed citations
10.
Yovino, Susannah, R. Taylor, Jeffrey S. Wolf, et al.. (2009). Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy. Head & Neck. 32(1). 46–52. 14 indexed citations
11.
Taylor, R., Young Kwok, Kevin J. Cullen, et al.. (2009). Race impacts outcome in stage III/IV squamous cell carcinomas of the head and neck after concurrent chemoradiation therapy. Cancer. 115(8). 1744–1752. 23 indexed citations
12.
Zimrin, Ann B. & John R. Hess. (2008). Current issues relating to the transfusion of stored red blood cells. Vox Sanguinis. 96(2). 93–103. 196 indexed citations
13.
Gonzalez‐Cuyar, Luis F., Fábio Távora, Allen Burke, et al.. (2007). Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature. Diagnostic Pathology. 2(1). 49–49. 8 indexed citations
14.
Taylor, R., Jeffrey S. Wolf, Young Kwok, et al.. (2007). Site as a Prognostic Factor in Patients With Stage III/IV Squamous Cell Carcinoma of the Head and Neck Following Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 69(3). S468–S468. 2 indexed citations
15.
Zimrin, Ann B. & John R. Hess. (2007). Planning for pandemic influenza: effect of a pandemic on the supply and demand for blood products in the United States. Transfusion. 47(6). 1071–1079. 30 indexed citations
16.
Zimrin, Ann B. & John R. Hess. (2007). Blood donors and the challenges in supplying blood products and factor concentrates. Surgery. 142(4). S15–S19. 8 indexed citations
17.
Zimrin, Ann B., Richard P. Dutton, Maureen McCunn, & John R. Hess. (2005). Management of Postinjury Coagulopathy. Transfusion Alternatives in Transfusion Medicine. 6(4). 37–41. 1 indexed citations
18.
Hess, John R. & Ann B. Zimrin. (2005). Massive blood transfusion for trauma. Current Opinion in Hematology. 12(6). 488–492. 42 indexed citations
19.
Zimrin, Ann B., Michael S. Pepper, Grainne A. McMahon, et al.. (1996). An Antisense Oligonucleotide to the Notch Ligand Jagged Enhances Fibroblast Growth Factor-induced Angiogenesis in Vitro. Journal of Biological Chemistry. 271(51). 32499–32502. 122 indexed citations
20.
Zimrin, Ann B., R Eisman, Gaston Vilaire, et al.. (1988). Structure of platelet glycoprotein IIIa. A common subunit for two different membrane receptors.. Journal of Clinical Investigation. 81(5). 1470–1475. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026